EUVIMEDScopri EUVIMED
EditorialKommentar

Is FeNOtyping in COPD the path to precision medicine?

Cara Flynn, Chris Brightling iD

Respirology · 2023-05 · 28 (5) · 421-422

DOI: 10.1111/resp.14474 ↗

At a glance

Editorial in Respirology, published online on 2023-02-21. Written by Cara Flynn and 1 co-authors. Institution: NIHR Biomedical Research Centre, Institute for Lung Health, University of Leicester, Leicester, UK. Major MEDLINE topics: Pulmonary Disease, Chronic Obstructive, Asthma. Cited 12 times so far (Crossref); 14 references. Funded by: NIHR Biomedical Research Centre Leicester.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

See related article

Subjects

MeSH terms (MEDLINE)

Pulmonary Disease, Chronic ObstructiveAsthmaHumansPrecision MedicineNitric OxideBreath Tests

Author keywords

COPDFeNOasthmachronic obstructive pulmonary diseaseinflammationprecision medicine

Substances

Nitric Oxide

Authors and institutions

  • NIHR Biomedical Research Centre, Institute for Lung Health, University of Leicester, Leicester, UK.

ORCID profiles: Chris Brightling

Funding

  • NIHR Biomedical Research Centre Leicester

Cite

APA

Flynn, C., & Brightling, C. (2023). Is FeNOtyping in COPD the path to precision medicine?. Respirology, 28(5), 421-422. https://doi.org/10.1111/resp.14474

Vancouver

Flynn C, Brightling C. Is FeNOtyping in COPD the path to precision medicine?. Respirology. 2023;28(5):421-422. doi:10.1111/resp.14474

BibTeX
@article{Flynn2023,
  author = {Flynn, Cara and Brightling, Chris},
  title = {Is FeNOtyping in COPD the path to precision medicine?},
  journal = {Respirology},
  year = {2023},
  volume = {28},
  number = {5},
  pages = {421--422},
  doi = {10.1111/resp.14474}
}
Start for free →